CLASS I Drug recall · Reported 19 Sep 2018 · FDA Enforcement Report

Thyroveev, Homeopathic recalled by Hellolife

Hellolife is recalling Thyroveev, Homeopathic (, distributed nationwide in the US. The recall was initiated on 23 Aug 2018 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot: TV/030717F, exp 7/2019
Quantity recalled370 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1202-2018
FDA event ID
80893
Recalling firm
Hellolife, Grand Rapids, MI
Classification
Class I
Status
Terminated
Recall initiated
23 Aug 2018
FDA classified
17 Sep 2018
Reported
19 Sep 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

23 Aug 2018Recall initiated by company
17 Sep 2018Classified by FDA+25 days
19 Sep 2018Published in enforcement report+2 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Thyroveev, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: HelloLife, Inc. 4635 40th St SE, Grand Rapids, MI 49512. NDC: 49726-025-02

Where it was distributed

Nationwide USA, Algeria Australia Belgium Brazil Bulgaria Canada Colombia Croatia Cyprus Czech Republic Denmark Dominican Republic Ecuador Estonia French Polynesia Greece Guadeloupe Guam Hong Kong Hungary India Ireland Israel Italy Latvia Lithuania Martinique Mexico Monaco Netherlands New Zealand Norway Peru Poland Portugal Romania Russia Russian Federation Saudi Arabia Senegal Serbia Slovakia Slovakia (Slovak Republic) Slovenia Swaziland Sweden Switzerland Taiwan Turkey United Kingdom

Nationwide

Questions about this recall

Is Thyroveev, Homeopathic ( recalled?

Yes. Hellolife recalled Thyroveev, Homeopathic ( on 23 Aug 2018. The recall is Class I and its status is Terminated. Recall number D-1202-2018.

Why was it recalled?

Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia

Which lots are affected?

Lot: TV/030717F, exp 7/2019

Where was it sold?

Nationwide USA, Algeria Australia Belgium Brazil Bulgaria Canada Colombia Croatia Cyprus Czech Republic Denmark Dominican Republic Ecuador Estonia French Polynesia Greece Guadeloupe Guam Hong Kong Hungary India Ireland Israel Italy Latvia Lithuania Martinique Mexico Monaco Netherlands New Zealand Norway Peru Poland Portugal Romania Russia Russian Federation Saudi Arabia Senegal Serbia Slovakia Slovakia (Slovak Republic) Slovenia Swaziland Sweden Switzerland Taiwan Turkey United Kingdom

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hellolife

All 4
ReportedClassRecallCompanyReasonWhere
DrugCLASS INeuroveen, Homeopathic recalled by HellolifeHellolifeSterilityNationwide
DrugCLASS ICompulsin, Homeopathic recalled by HellolifeHellolifeSterilityNationwide
DrugCLASS IRespitrol, Homeopathic recalled by HellolifeHellolifeSterilityNationwide